[1st considerations on the therapeutic contribution of p-butoxyphenylacethydroxamic acid (Droxaryl) in physical medicine].
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002062:Bursitis / Q000188:drug therapy; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D007592:Joint Diseases / Q000188:drug therapy*; D007659:Ketones / Q000627:therapeutic use; D009437:Neuralgia / Q000188:drug therapy; D010003:Osteoarthritis / Q000188:drug therapy; D010648:Phenylacetates / Q000627:therapeutic use; D013717:Tenosynovitis / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D006877:Hydroxamic Acids; D007659:Ketones; D010648:Phenylacetates
Premières considérations sur l'apport thérapeutique de l'acide p-butoxyphŕnylacéthydroxamique (Droxaryl) en médecine physique.